Gamma Investing LLC Argenx Se Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Argenx Se stock. As of the latest transaction made, Gamma Investing LLC holds 118 shares of ARGX stock, worth $64,721. This represents 0.01% of its overall portfolio holdings.
Number of Shares
118
Previous 78
51.28%
Holding current value
$64,721
Previous $30.7 Million
65.24%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ARGX
# of Institutions
371Shares Held
31.4MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.07 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.93 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.35 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.06 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$829 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $30.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...